|
In light of the new Bioscreen laboratory tests for CFIDS (urinary markers CFIDSUM1, B15, etc.), it is noteworthy that four Australian patients who, after following Dr Petrovic's research-based treatment procedure, were found to no longer meet the CDC CFIDS criteria, also showed an absence of their previously detected urinary CFIDS markers.
These preliminary observations suggest a possible correlation between clinical improvement and changes in Bioscreen laboratory markers; however, further independent verification and controlled research would be required to confirm these findings.
|